GO From the Editor's Desk
|
 Just Released! What Lies Ahead for 2013?
DIA's first annual What Lies Ahead? report, provides expert insight into the year ahead for pharmaceuticals, biotechnology, and the product development of medical devices.
Read report.
 Insider Update
With less than two months away from the kick off of DIA 2013 49th Annual Meeting, we wanted to bring you this Special Edition of the Insider Update to provide insight from key thought leaders.
Read More to get the inside scoop!
 Global Forum
Special Section: AIDS at 30: AIDS Retrospective from a Patient Advocacy Perspective: The AIDS epidemic has driven forward a new era of patient engagement and advocacy, therapeutic innovation and regulatory science. This section explores and explains the history of ACT-UP in the US, HIV/AIDS patient advocacy with the European Medicines Agency, and more, plus reflections from Richard Klein, Director of the FDA’s Patient Liaison Program, Office of Health and Constituent Affairs.
Read the April issue. |
|
|
|
|
|
|
 Editor-in-Chief's Commentary: Therapeutic Innovation & Regulatory Science | May 2013
Read full commentary.
 New! Content Currents
DIA's Content Currents provides important new global regulatory developments and their impact on pharmaceutical, biotechnology, and medical product development.
Read current issue.
 Exploring Impact of ‘US v. Caronia’
Read article.
|
GO Newsroom
|
DIA Releases First Annual What Lies Ahead? Report
This inaugural What Lies Ahead? report provides expert insight into the year ahead for pharmaceuticals, biotechnology, and the product development of medical devices.
Read press release.
The Randomized Clinical Trial at the 50th Anniversary of the Kefauver-Harris Amendments
This White Paper celebrates the 50th Anniversary of the Kefauver-Harris Amendments to the Food, Drug, and Cosmetic Act, which were signed into law by President John F. Kennedy on 10th October, 1962. Since then, the well-conducted RCT has become the gold standard for generating evidence of efficacy.
Download white paper.
New Executive Director Profile
DIA is actively engaged in an executive search to find a successor to Worldwide Executive Director Paul Pomerantz, who announced his resignation in late November. Korn/Ferry International has been retained by the DIA Board of Directors to conduct this search and is currently pursuing candidates and accepting resumes for this position.
Read profile.
|
|
|
|
|
|
|
|
DIA Today
DIA Today is a daily online newspaper featuring articles, blog posts, videos, and photos from hundreds of global trade and general media outlets.
Read today's issue.
Today's Top Story
Drug Repositioning: A New Path to Address Unmet Clinical Needs
Read article.
|
|
GO DIA 2013 49th Annual Meeting
Less than Two Months until DIA 2013 49th Annual Meeting Takes Over Boston
Join more than 7,000 life sciences professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related products to unlock the innovation needed to expand global access to effective and affordable patient care. Get your name alongside top thought leaders, innovators, and experts all seeking fresh knowledge and sharpening their skills for the future. You must be registered by May 17 to be included in the Advance Attendee List.
Search 250+ educational offerings across 22 tracks with the Online Searchable Program or view the Preliminary Program online. What’s more, you can search by:
Track | Special Topics | Credits | Day
DIA 2013 49th Annual Meeting Highlights:
Register
GO Meetings & Training
Educational Opportunities
DIA’s comprehensive education and training opportunities are designed by and for a global audience of regulatory, academic, industry, and patient advocate professionals and experts working throughout the medical product industry.
All of DIA’s education and training opportunities are open, neutral platforms for discussing and learning more about critical issues, challenges, and opportunities to improve medical product innovation. Professional development options include:
Upcoming educational opportunities in your region:
Europe Training Catalogue
Read
eLearning Catalog
Read
GO Member Benefits
New! Free access to one of DIA's archived webinars featuring up-to-the-minute information about the latest developments in the medical product industry
Just added! The Impact of Drug Shortages on the Pharmaceutical Industry
More than 18,000 members worldwide look to DIA as the only global, neutral, nonprofit, multidisciplinary association to address the challenges you face every day. Take advantage of all the benefits of membership, including:
DIA ConneX is a trusted, interactive, web-based network that links DIA’s 18,000-member global community. DIA members use ConneX to collaborate, communicate, network, and exchange information. Through ConneX, DIA members:
- Share documents
- Engage in online discussions
- Post community event information
- Make announcements and post news
- Join Communities (formerly SIACs)
GO Exhibiting & Advertising
Showcase your company's products or services to key decision-makers from across the pharmaceutical, biotechnology, medical device, and related fields.
Contract Service Organization (CSO) Directory
Reserve your spot in our exclusive print and online partner directory featuring full-page descriptions and contact information for yours and other clinical trial and medical product development service companies around the world.
View partner listings.
Exhibiting Opportunities
Join DIA and an anticipated 450+ companies with a booth at the DIA 2013 49th Annual Meeting!
Upcoming exhibiting opportunities in your region:
Advertise your company's products and services to professionals from the pharmaceutical, biotechnology, medical device, and related sectors.
Advertise
Place your advertising message in front of more than 18,000 professionals involved in every aspect of medical product discovery, development, and delivery.
Advertise
GO Communities Showcase
New Era for Communities
DIA is a global member association that provides knowledge resources across the full spectrum of medical product development. In the last few years the organization has expanded that global reach and will continue to grow to meet the need for health care knowledge exchange around the world.
As DIA’s reach expands globally we believe a name change is necessary. Our global volunteers came to consensus on "Community" to replace "SIACs." This change will enhance the visibility of the groups and make it much easier to recognize their purpose.
Each Community is led by a chairperson who is responsible for the overall activities of the Community. View complete list of Community chairpersons.
GO Student Initiatives
DIA offers students many opportunities to get involved and contribute in a collegial, inclusive, collaborative, positive, respectful, and professional environment in support of DIA’s mission. available student opportunities include:
- Student Volunteer Program
- Young Professionals Fellowship Program
- Student Fellowship Program
- Complimentary EuroMeeting registration
- Student Poster Session (North America, Europe, China Annual Meetings)
- Discount registration (North America and Europe Annual Meetings)
- Group Discounts for DIA Student Chapter members
- Student Membership
- Student Engagement at DIA Annual Meeting
- Student Chapters
Featured Story
Medical Students Remain Unfazed by Professors Industry Relationships
Read article.
Featured Video
Medical Genetics Residency Programs: Medical Genetics is Transforming Medicine
GO Patient Initiatives
Through DIA’s worldwide conferences and programs, patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices.
Help Reduce Your Risk of Birth Defects
Watch this video from the National Birth Defects Prevention Network (NBDPN), a volunteer-based organization that addresses the issues of birth defects surveillance, research and prevention under one umbrella by maintaining a national network of state and population-based birth defects programs.
Patient organizations play a key role in the DIA 2013 49th Annual Meeting Program. Patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices. DIA is working to ensure that the "voice of the patient' is heard globally in every facet of the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related products.
DIA and NORD invite patient organizations and patients to attend the US Conference on Rare Diseases and Orphan Products to network with other stakeholders in the rare diseases community.
The EuroMeeting Patient Fellowship Program is designed to:
Develop, strengthen, and support patient collaborations with policy makers, health professionals, industry representatives, and academia;
Increase the knowledge and understanding of patient groups about key issues central to patient-centered healthcare, biomedical research, and drug development;
Develop the capacity of patient groups to advocate for change;
Improve alliances between patient groups and other healthcare stakeholders; and
Stimulate cooperation, promote dialogue, and share best practices.